why choose us

First received: November 16, 2022

Clinical Trial: Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation

Study Status: Completed

Recruit Status: Completed

Condition: Safety
Bioavailability
Pharmacokinetics

Study Type: Interventional


Official Title: A Randomized, Single Dose, Crossover Study in Healthy Volunteers to Investigate the Relative Bioavailability of Linaprazan for a New Oral Tablet Formulation of Linaprazan Glurate, and to Assess the Ef

Brief Summary: This is a single-center, open-label, randomized, single dose, 3-way crossover study in healthy volunteers designed to evaluate the relative bioavailability of a new oral tablet formulation of linaprazan glurate in comparison to a previously studied oral tablet formulation under fasting conditions, and to assess the effect of a high fat, high calorie meal on the pharmacokinetics (PK) of linaprazan glurate and the active substance linaprazan after the administration of the new oral tablet formulation.

Read more